Gross profit was $1.4 million, an increase of 15.4%, and $3.7 million, a decrease of 4.4%, respectively, for the three- and nine-month periods ended September 30, 2024, compared to $1.2 million, and ...

Bio-Rad is a leader in niche areas including quality controls, antigens, and digital PCR, and it has a strong razor-and-blade ...

Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Good day, and welcome to the Accelerate Diagnostics Inc. Third Quarter 2024 Earnings Conference Call. All participants will be in a ...